Vaccination of feedlot cattle with extracts and membrane fractions from two Mycoplasma bovis isolates results in strong humoral immune responses but does not protect against an experimental challenge

Vaccine

Volumn 31, Issue 10, 2013, Pages 1406-1412

  Mulongo, Musa ^a   Prysliak, Tracy ^a   Perez Casal, Jose ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cattle; CpG; Mycoplasma bovis; Vaccines

Indexed keywords

BACTERIAL VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE 2007; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MYCOPLASMA BOVIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL; BACTERIAL IMMUNITY; BACTERIUM ISOLATE; BLOOD SAMPLING; CATTLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG FEVER; EXPERIMENTAL ANIMAL; HUMORAL IMMUNITY; MYCOPLASMA BOVIS; MYCOPLASMOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TH1 CELL; TH2 CELL; VACCINATION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; CELL MEMBRANE; CELL PROLIFERATION; LEUKOCYTES, MONONUCLEAR; MYCOPLASMA BOVIS; MYCOPLASMA INFECTIONS; OLIGODEOXYRIBONUCLEOTIDES; PNEUMONIA, MYCOPLASMA; VACCINATION; VACCINES, SUBUNIT;

EID: 84875809067     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.055     Document Type: Article

References (19)

1. Arcangioli M.A., Duet A., Meyer G., Dernburg A., Bezille P., Poumarat F., et al. The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlots. Vet J 2008, 177(July (1)):89-93.
2. Maunsell F.P., Woolums A.R., Francoz D., Rosenbusch R.F., Step D.L., Wilson D.J., et al. Mycoplasma bovis infections in cattle. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2011, 25(July-August (4)):772-783.
3. Lysnyansky I., Rosengarten R., Yogev D. Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangements. J Bacteriol 1996, 178(September (18)):5395-5401.
4. Lysnyansky I., Sachse K., Rosenbusch R., Levisohn S., Yogev D. The vsp locus of Mycoplasma bovis: gene organization and structural features. J Bacteriol 1999, 181(September (18)):5734-5741.
5. van der Merwe J., Prysliak T., Perez-Casal J. Invasion of bovine peripheral-blood mononuclear cells and erythrocytes by Mycoplasma bovis. Infect Immun 2010, 78(August (11)):4570-4578.
6. Chima J.C., Wilkie B.N., Ruhnke H.L., Truscott R.B., Curtis R.A. Immunoprophylaxis of experimental Mycoplasma bovis arthritis in calves. Protective efficacy of live organisms and formalinized vaccines. Vet Microbiol 1980, 5:113-122.
7. Howard C.J., Stott E.J., Thomas L.H., Gourlay R.N., Taylor G. Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus, parainfluenza type 3 virus, Mycoplasma bovis and M. dispar. Vet Rec 1987, 121(October (16)):372-376.
8. Nicholas R.A., Ayling R.D., Stipkovits L.P. An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings. Vaccine 2002, 20(October (29-30)):3569-3575.
9. Hermeyer K., Buchenau I., Thomasmeyer A., Baum B., Spergser J., Rosengarten R., et al. Chronic pneumonia in calves after experimental infection with Mycoplasma bovis strain 1067: characterization of lung pathology, persistence of variable surface protein antigens and local immune response. Acta Vet Scand 2012, 54(1):9.
10. Vanden Bush T.J., Rosenbusch R.F. Characterization of the immune response to Mycoplasma bovis lung infection. Vet Immunol Immunopathol 2003, 94(July (1-2)):23-33.
11. Howard C.J. Comparison of bovine IgG1, IgG2 and IgM for ability to promote killing of Mycoplasma bovis by bovine alveolar macrophages and neutrophils. Vet Immunol Immunopathol 1984, 6(July (3-4)):321-326.
12. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 2002, 21(November (1-2)):127-137.
13. Prysliak T., Van der Merwe J., Lawman Z., Wilson D., Townsend H., van Drunen Littel-van den Hurk S., et al. Respiratory disease caused by Mycoplasma bovis is enhanced by exposure to Bovine Herpes Virus 1 (BHV-1) and not to Bovine Viral Diarrhoea Virus (BVDV) type 2. Can Vet J 2011, 52:1195-1202.
14. Perez-Casal J., Prysliak T. Detection of antibodies against the Mycoplasma bovis glyceraldehyde-3-phosphate dehydrogenase protein in beef cattle. Microb Pathog 2007, 43(November-December (5-6)):189-197.
15. Howard C.J., Thomas L.H., Parsons K.R. Immune response of cattle to respiratory mycoplasmas. Vet Immunol Immunopathol 1987, 17(December (1-4)):401-412.
16. Boothby J.T., Jasper D.E., Thomas C.B. Experimental intramammary inoculation with Mycoplasma bovis in vaccinated and unvaccinated cows: effect on local and systemic antibody response. Canadian Journal of Veterinary Research=Revue Canadienne de Recherche Veterinaire 1987, 51(January (1)):121-125.
17. Maunsell F.P., Donovan G.A., Risco C., Brown M.B. Field evaluation of a Mycoplasma bovis bacterin in young dairy calves. Vaccine 2009, 27(May (21)):2781-2788.
18. Vanden Bush T.J., Rosenbusch R.F. Characterization of a lympho-inhibitory peptide produced by Mycoplasma bovis. Biochem Biophys Res Commun 2004, 315(March (2)):336-341.
19. Thomas C.B., Mettler J., Sharp P., Jensen-Kostenbader J., Schultz R.D. Mycoplasma bovis suppression of bovine lymphocyte response to phytohemagglutinin. Vet Immunol Immunopathol 1990, 26(October (2)):143-155.